Скачать или смотреть Breast Cancer Explained | Symptoms & Treatment in Hindi | Dr. Ravi Jaiswal

In this episode of The Cancer Conversation, Dr. Ravi Jaiswal ‪@drravijaiswal-raipur‬ Consultant Oncologist at RamKrishna CARE Hospitals, Raipur, explains in simple Hindi about breast cancer—its symptoms, causes, risk factors, diagnosis, prevention, and treatment options available today.

This podcast aims to help the general public understand the importance of early detection, self-examination, and timely treatment to improve patient outcomes.

🔔 Subscribe to our channel and press the bell icon for more expert-led, awareness-focused videos on cancer care.

About The Cancer Conversation:
This podcast series is brought to you by Delarc Pharmaceuticals, an oncological pharma company dedicated to patient education and better cancer care.

About Delarc Pharmaceuticals:
Delarc Pharmaceuticals is committed to improving oncology care by enabling access to quality treatment, driving patient-centric initiatives, and supporting educational platforms like The Cancer Conversation to build a more informed India.

Follow Delarc:
LinkedIn: in.linkedin.com/company/delarc-pharmaceuticals
Website: www.delarc.in

⚠️ Disclaimer:
This video is intended for general informational and educational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider with any questions you may have regarding a medical condition.
Delarc Pharmaceuticals does not provide medical advice and does not endorse any specific treatment mentioned. The views expressed are solely those of the guest speaker.

#BreastCancerAwareness #BreastCancer #CancerAwareness #BreastCancerSymptoms #BreastCancerPrevention #BreastCancerDiagnosis #BreastCancerTreatment #Oncology #DrRaviJaiswal #CAREHospitals #Raipur #HindiPodcast #TheCancerConversation #DelarcPharmaceuticals

© 2025 Delarc Pharmaceuticals. All rights reserved.
Unauthorized reproduction, distribution, or re-uploading of this video content—either in full or in part—is strictly prohibited without prior written consent from Delarc Pharmaceuticals.